關於 Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Source: Wikipedia
總部251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
成立時間2018
狀態營運中

專利1 項專利

GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019

在 Heelky 上搜尋所有專利 →

評價

尚無評論。與 Assertio Therapeutics, Inc. 合作過嗎?成為第一個分享經驗的人吧。

撰寫評論 →

地點

251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US

這是你的公司嗎?

免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。

認領此頁面

分享這家公司

Assertio Therapeutics, Inc.251 LITTLE FALLS DRIVE, 19808, WILMINGTON, UShttps://heelky.com/explore/companies/assertio-therapeutics-inc-ur37rgl2/

複製連結

分享到

QR Code

用手機相機掃描即可開啟此頁面,也可以下載用於傳單、簡報或名牌。

加入 Heelky,建立人脈、招募人才、持續成長

建立免費帳號,即可傳送訊息、應徵職缺並發布任務。

立即加入 — 完全免費

選擇語言

Heelky 會記住你的選擇。

其他語言

可用語言:70 關於 Heelky 的語言